Technical Analysis for HROW - Harrow Health, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| NR7 | Range Contraction | -0.36% | |
| 180 Bullish Setup | Bullish Swing Setup | -4.01% | |
| MACD Bearish Signal Line Cross | Bearish | -0.83% | |
| Overbought Stochastic | Strength | -0.83% | |
| Slingshot Bullish | Bullish Swing Setup | -2.11% | |
| Overbought Stochastic | Strength | -2.11% | |
| MACD Bullish Signal Line Cross | Bullish | -5.16% |
| Alert | Time |
|---|---|
| Fell Below Previous Day's Low | about 11 hours ago |
| Down 1% | about 11 hours ago |
| 60 Minute Opening Range Breakdown | about 11 hours ago |
| Possible NR7 | about 12 hours ago |
| Possible Inside Day | about 12 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 11/11/2024
Harrow Health, Inc. Description
Harrow Health, Inc., formerly Imprimis Pharmaceuticals, Inc., is engaged in the development, production and dispensing of compounded pharmaceuticals. The Company operates through the business of developing drug therapies and providing such therapies through sterile and non-sterile pharmaceutical compounding services segment. The Company owns, markets and dispenses a portfolio of compounded therapeutic in several therapeutic areas, including ophthalmology, urology, otolaryngology and infectious diseases. The Company is also developing Custom Compounding Choice business, which is focused on developing and dispensing a portfolio of non-proprietary compounded drugs for humans and animals in therapeutic areas that may be overlooked by commercial pharmaceutical companies. The Company also offers customizable compounding products that consist of sterile injectable and non-sterile integrative medicine therapies that are used in various therapeutic areas.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Infectious Diseases Pharmacy Ophthalmology Urology Pharmaceutical Sciences Drug Therapies Compounding
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 47.49 |
| 52 Week Low | 7.6 |
| Average Volume | 575,177 |
| 200-Day Moving Average | 19.22 |
| 50-Day Moving Average | 36.35 |
| 20-Day Moving Average | 42.66 |
| 10-Day Moving Average | 44.75 |
| Average True Range | 2.13 |
| RSI (14) | 58.85 |
| ADX | 40.97 |
| +DI | 25.38 |
| -DI | 15.11 |
| Chandelier Exit (Long, 3 ATRs) | 41.09 |
| Chandelier Exit (Short, 3 ATRs) | 44.13 |
| Upper Bollinger Bands | 47.78 |
| Lower Bollinger Band | 37.55 |
| Percent B (%b) | 0.64 |
| BandWidth | 23.98 |
| MACD Line | 2.29 |
| MACD Signal Line | 2.66 |
| MACD Histogram | -0.3705 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 46.39 | ||||
| Resistance 3 (R3) | 46.42 | 45.68 | 46.00 | ||
| Resistance 2 (R2) | 45.68 | 45.09 | 45.66 | 45.87 | |
| Resistance 1 (R1) | 44.87 | 44.72 | 44.50 | 44.84 | 45.74 |
| Pivot Point | 44.13 | 44.13 | 43.95 | 44.12 | 44.13 |
| Support 1 (S1) | 43.33 | 43.54 | 42.96 | 43.30 | 42.40 |
| Support 2 (S2) | 42.59 | 43.18 | 42.57 | 42.27 | |
| Support 3 (S3) | 41.78 | 42.59 | 42.14 | ||
| Support 4 (S4) | 41.75 |
